Eintrag weiter verarbeiten
C‐reactive protein and the treatment of pelvic inflammatory disease
Gespeichert in:
| Zeitschriftentitel: | International Journal of Gynecology & Obstetrics |
|---|---|
| Personen und Körperschaften: | , |
| In: | International Journal of Gynecology & Obstetrics, 60, 1998, 2, S. 143-150 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
Reljič, M Gorišek, B Reljič, M Gorišek, B |
|---|---|
| author |
Reljič, M Gorišek, B |
| spellingShingle |
Reljič, M Gorišek, B International Journal of Gynecology & Obstetrics C‐reactive protein and the treatment of pelvic inflammatory disease Obstetrics and Gynecology General Medicine |
| author_sort |
reljič, m |
| spelling |
Reljič, M Gorišek, B 0020-7292 1879-3479 Wiley Obstetrics and Gynecology General Medicine http://dx.doi.org/10.1016/s0020-7292(97)00236-1 <jats:title>Abstract</jats:title><jats:sec><jats:label /><jats:p><jats:italic>Objective:</jats:italic> The significance of C‐reactive protein (CRP) in assessing the treatment of pelvic inflammatory disease (PID) was established and compared with body temperature (BT), erythrocyte sedimentation rate (ESR) and serum leukocyte concentration (L). <jats:italic>Method:</jats:italic> In 51 patients with PID, 20 (39%) of them with tubo‐ovarial abscess (TOA), measurement of BT and laboratory investigations were carried out on admission and during treatment on days 3–4, 6–8 and 18–21. The changes in these values were compared with the changes in clinical condition. <jats:italic>Result:</jats:italic> Prior to treatment, the majority — 49 patients or 96.1% — had increased CRP values. In successful treatment, the CRP values decreased significantly in PID patients without TOA on day 3–4, in patients with TOA on day 6–8 and reached normal values in both groups on day 18–21. Changes in clinical condition were most concurrent with changes in CRP. <jats:italic>Conclusion:</jats:italic> In assessing PID treatment, the determination of CRP has precedence over L, ESR and BT as the percentage of patients with increased CRP is higher and because the changes in value follow the changes in clinical condition more reliably.</jats:p></jats:sec> C‐reactive protein and the treatment of pelvic inflammatory disease International Journal of Gynecology & Obstetrics |
| doi_str_mv |
10.1016/s0020-7292(97)00236-1 |
| facet_avail |
Online |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9zMDAyMC03MjkyKDk3KTAwMjM2LTE |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9zMDAyMC03MjkyKDk3KTAwMjM2LTE |
| institution |
DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Rs1 DE-Pl11 |
| imprint |
Wiley, 1998 |
| imprint_str_mv |
Wiley, 1998 |
| issn |
0020-7292 1879-3479 |
| issn_str_mv |
0020-7292 1879-3479 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
reljic1998creactiveproteinandthetreatmentofpelvicinflammatorydisease |
| publishDateSort |
1998 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
International Journal of Gynecology & Obstetrics |
| source_id |
49 |
| title |
C‐reactive protein and the treatment of pelvic inflammatory disease |
| title_unstemmed |
C‐reactive protein and the treatment of pelvic inflammatory disease |
| title_full |
C‐reactive protein and the treatment of pelvic inflammatory disease |
| title_fullStr |
C‐reactive protein and the treatment of pelvic inflammatory disease |
| title_full_unstemmed |
C‐reactive protein and the treatment of pelvic inflammatory disease |
| title_short |
C‐reactive protein and the treatment of pelvic inflammatory disease |
| title_sort |
c‐reactive protein and the treatment of pelvic inflammatory disease |
| topic |
Obstetrics and Gynecology General Medicine |
| url |
http://dx.doi.org/10.1016/s0020-7292(97)00236-1 |
| publishDate |
1998 |
| physical |
143-150 |
| description |
<jats:title>Abstract</jats:title><jats:sec><jats:label /><jats:p><jats:italic>Objective:</jats:italic> The significance of C‐reactive protein (CRP) in assessing the treatment of pelvic inflammatory disease (PID) was established and compared with body temperature (BT), erythrocyte sedimentation rate (ESR) and serum leukocyte concentration (L). <jats:italic>Method:</jats:italic> In 51 patients with PID, 20 (39%) of them with tubo‐ovarial abscess (TOA), measurement of BT and laboratory investigations were carried out on admission and during treatment on days 3–4, 6–8 and 18–21. The changes in these values were compared with the changes in clinical condition. <jats:italic>Result:</jats:italic> Prior to treatment, the majority — 49 patients or 96.1% — had increased CRP values. In successful treatment, the CRP values decreased significantly in PID patients without TOA on day 3–4, in patients with TOA on day 6–8 and reached normal values in both groups on day 18–21. Changes in clinical condition were most concurrent with changes in CRP. <jats:italic>Conclusion:</jats:italic> In assessing PID treatment, the determination of CRP has precedence over L, ESR and BT as the percentage of patients with increased CRP is higher and because the changes in value follow the changes in clinical condition more reliably.</jats:p></jats:sec> |
| container_issue |
2 |
| container_start_page |
143 |
| container_title |
International Journal of Gynecology & Obstetrics |
| container_volume |
60 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792335905328988161 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T14:51:59.06Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=C%E2%80%90reactive+protein+and+the+treatment+of+pelvic+inflammatory+disease&rft.date=1998-02-01&genre=article&issn=1879-3479&volume=60&issue=2&spage=143&epage=150&pages=143-150&jtitle=International+Journal+of+Gynecology+%26+Obstetrics&atitle=C%E2%80%90reactive+protein+and+the+treatment+of+pelvic+inflammatory+disease&aulast=Gori%C5%A1ek&aufirst=B&rft_id=info%3Adoi%2F10.1016%2Fs0020-7292%2897%2900236-1&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792335905328988161 |
| author | Reljič, M, Gorišek, B |
| author_facet | Reljič, M, Gorišek, B, Reljič, M, Gorišek, B |
| author_sort | reljič, m |
| container_issue | 2 |
| container_start_page | 143 |
| container_title | International Journal of Gynecology & Obstetrics |
| container_volume | 60 |
| description | <jats:title>Abstract</jats:title><jats:sec><jats:label /><jats:p><jats:italic>Objective:</jats:italic> The significance of C‐reactive protein (CRP) in assessing the treatment of pelvic inflammatory disease (PID) was established and compared with body temperature (BT), erythrocyte sedimentation rate (ESR) and serum leukocyte concentration (L). <jats:italic>Method:</jats:italic> In 51 patients with PID, 20 (39%) of them with tubo‐ovarial abscess (TOA), measurement of BT and laboratory investigations were carried out on admission and during treatment on days 3–4, 6–8 and 18–21. The changes in these values were compared with the changes in clinical condition. <jats:italic>Result:</jats:italic> Prior to treatment, the majority — 49 patients or 96.1% — had increased CRP values. In successful treatment, the CRP values decreased significantly in PID patients without TOA on day 3–4, in patients with TOA on day 6–8 and reached normal values in both groups on day 18–21. Changes in clinical condition were most concurrent with changes in CRP. <jats:italic>Conclusion:</jats:italic> In assessing PID treatment, the determination of CRP has precedence over L, ESR and BT as the percentage of patients with increased CRP is higher and because the changes in value follow the changes in clinical condition more reliably.</jats:p></jats:sec> |
| doi_str_mv | 10.1016/s0020-7292(97)00236-1 |
| facet_avail | Online |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9zMDAyMC03MjkyKDk3KTAwMjM2LTE |
| imprint | Wiley, 1998 |
| imprint_str_mv | Wiley, 1998 |
| institution | DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Rs1, DE-Pl11 |
| issn | 0020-7292, 1879-3479 |
| issn_str_mv | 0020-7292, 1879-3479 |
| language | English |
| last_indexed | 2024-03-01T14:51:59.06Z |
| match_str | reljic1998creactiveproteinandthetreatmentofpelvicinflammatorydisease |
| mega_collection | Wiley (CrossRef) |
| physical | 143-150 |
| publishDate | 1998 |
| publishDateSort | 1998 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | International Journal of Gynecology & Obstetrics |
| source_id | 49 |
| spelling | Reljič, M Gorišek, B 0020-7292 1879-3479 Wiley Obstetrics and Gynecology General Medicine http://dx.doi.org/10.1016/s0020-7292(97)00236-1 <jats:title>Abstract</jats:title><jats:sec><jats:label /><jats:p><jats:italic>Objective:</jats:italic> The significance of C‐reactive protein (CRP) in assessing the treatment of pelvic inflammatory disease (PID) was established and compared with body temperature (BT), erythrocyte sedimentation rate (ESR) and serum leukocyte concentration (L). <jats:italic>Method:</jats:italic> In 51 patients with PID, 20 (39%) of them with tubo‐ovarial abscess (TOA), measurement of BT and laboratory investigations were carried out on admission and during treatment on days 3–4, 6–8 and 18–21. The changes in these values were compared with the changes in clinical condition. <jats:italic>Result:</jats:italic> Prior to treatment, the majority — 49 patients or 96.1% — had increased CRP values. In successful treatment, the CRP values decreased significantly in PID patients without TOA on day 3–4, in patients with TOA on day 6–8 and reached normal values in both groups on day 18–21. Changes in clinical condition were most concurrent with changes in CRP. <jats:italic>Conclusion:</jats:italic> In assessing PID treatment, the determination of CRP has precedence over L, ESR and BT as the percentage of patients with increased CRP is higher and because the changes in value follow the changes in clinical condition more reliably.</jats:p></jats:sec> C‐reactive protein and the treatment of pelvic inflammatory disease International Journal of Gynecology & Obstetrics |
| spellingShingle | Reljič, M, Gorišek, B, International Journal of Gynecology & Obstetrics, C‐reactive protein and the treatment of pelvic inflammatory disease, Obstetrics and Gynecology, General Medicine |
| title | C‐reactive protein and the treatment of pelvic inflammatory disease |
| title_full | C‐reactive protein and the treatment of pelvic inflammatory disease |
| title_fullStr | C‐reactive protein and the treatment of pelvic inflammatory disease |
| title_full_unstemmed | C‐reactive protein and the treatment of pelvic inflammatory disease |
| title_short | C‐reactive protein and the treatment of pelvic inflammatory disease |
| title_sort | c‐reactive protein and the treatment of pelvic inflammatory disease |
| title_unstemmed | C‐reactive protein and the treatment of pelvic inflammatory disease |
| topic | Obstetrics and Gynecology, General Medicine |
| url | http://dx.doi.org/10.1016/s0020-7292(97)00236-1 |